Sun Pharma Launches Taro-Methylphenidate ER for ADHD
Mumbai, India and Brampton, Ontario, Canada, September 21, 2026 Sun Pharmaceutical Industries Limited (Sun Pharma) has announced the commercial...
ADHD
Advertisement
Otsuka Reports Phase 3b SIMTRIYO Data in ADHD and Anxiety
PRINCETON, N.J. and TOKYO, Japan — September 18, 2026 Otsuka Pharmaceutical presented new Phase 3b results for SIMTRIYO® (centanafadine)...
Alkermes Reports Positive Phase 1b ADHD Data for ALKS 7290
DUBLIN — September 21, 2026 Alkermes announced positive topline results from a Phase 1b proof-of-concept study of ALKS 7290,...
Tris Pharma Expands QuilliChew ER With 30-Count Bottle
MONMOUTH JUNCTION, N.J. — September 14, 2026 Tris Pharma, Inc. announced the availability of a new 30-count bottle size...
Ceribell Secures CMS NTAP for Delirium Monitor System
SUNNYVALE, Calif., Aug. 3, 2026 Ceribell, Inc. has secured a significant reimbursement milestone after the U.S. Centers for Medicare...
Advertisements
Supernus Pharmaceuticals and Indivior to Merge in $2.2 Billion CNS Biopharma Deal
ROCKVILLE, Md. & RICHMOND, Va., Aug. 3, 2026 Supernus Pharmaceuticals and Indivior Pharmaceuticals announced they have entered into a...
Otsuka’s SIMTRIYO® Becomes First Approved NDSRI for ADHD
PRINCETON, N.J., July 27, 2026 Otsuka Pharmaceutical Co., Ltd. and Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) have announced...
Otsuka Wins FDA Approval for First-in-Class SIMTRIYO for ADHD
PRINCETON, N.J. and TOKYO, Japan, July 24, 2026 Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical Co., Ltd....
Supernus Marks Five Years of Qelbree FDA Approval with Continued Growth in ADHD Treatment
ROCKVILLE, Md., July 14, 2026 Supernus Pharmaceuticals celebrated the fifth anniversary of the U.S. Food and Drug Administration (FDA)...
Otsuka Reports Positive Phase 3b Results for Centanafadine
TOKYO, Japan & PRINCETON, N.J., June 26, 2026 Otsuka Pharmaceutical Co., Ltd. and Otsuka Pharmaceutical Development & Commercialization, Inc....
Advertisement
